Matas Buzelis: Everything you need to know

Matas Buzelis

#14 SF

Chicago Bulls

Status

GTD - Ankle - Sprain Expected Return: 2026-10-01

STATS

Career Averages

PTS

REB

AST

BLK

STL

12.4

4.6

1.5

1.2

0.5

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	77	77	29.2	16.3	5.8	2.1	1.5	0.7	2.1	4	2.2	6.4	34.9%	3.5	6.1	58.3%	5.8	12.5	46.3%	2.4	3.1	78.6%	1.0	4.8	2.3	1.0	-306	58.6%
2024-25	80	31	18.9	8.6	3.5	1.0	0.9	0.4	0.9	1	1.2	3.3	36.1%	2.0	3.6	54.0%	3.2	6.9	45.4%	1.1	1.4	81.5%	0.7	2.8	1.6	1.1	-35	57.1%
Career	157	108	23.9	12.4	4.6	1.5	1.2	0.5	1.5	5	1.7	4.8	35.3%	2.7	4.8	56.7%	4.4	9.7	46.0%	1.8	2.2	79.5%	0.8	3.8	1.9	1.0	-341	58.1%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/16	MIN	W 126-120	24	19	1	1	2	1	1	5	2	40.0%	8	6	75.0%	13	8	61.5%	3	1	33.3%	0	1	1.0	-3	1	21	66.3%
10/14	DEN	L 124-117	30	20	3	1	5	0	4	7	3	42.9%	5	4	80.0%	12	7	58.3%	3	3	100.0%	0	3	0.3	-7	2	21	75.1%
10/12	MIL	L 127-121	24	19	4	0	0	0	1	6	2	33.3%	5	4	80.0%	11	6	54.5%	5	5	100.0%	0	4	0.0	-8	2	18	72.0%
10/9	CLE	W 119-112	19	11	2	0	1	1	2	5	2	40.0%	2	1	50.0%	7	3	42.9%	4	3	75.0%	1	1	0.0	-7	3	8	62.8%
10/7	CLE	W 118-117	18	19	8	1	1	0	2	5	2	40.0%	6	5	83.3%	11	7	63.6%	4	3	75.0%	5	3	0.5	-10	0	25	74.5%
Preseason Totals			23.3	17.6	3.6	0.6	1.8	0.4	2.0	5.6	2.2	39.3%	5.2	4.0	76.9%	10.8	6.2	57.4%	3.8	3.0	78.9%	1.2	2.4	0.3	-35	1.6	20.2	70.6%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/3	NYK	L 136-96	23	11	6	0	0	0	3	5	1	20.0%	4	3	75.0%	9	4	44.4%	4	2	50.0%	0	6	0.0	-19	4	5	51.1%
4/1	IND	L 145-126	28	17	9	6	0	2	4	7	3	42.9%	4	2	50.0%	11	5	45.5%	4	4	100.0%	0	9	1.5	-18	1	25	66.6%
3/30	SAS	L 129-114	27	12	6	2	3	1	2	6	1	16.7%	6	4	66.7%	12	5	41.7%	1	1	100.0%	0	6	1.0	-28	2	13	48.2%
3/28	MEM	L 125-124	38	29	10	3	3	1	4	10	3	30.0%	11	7	63.6%	21	10	47.6%	7	6	85.7%	1	9	0.8	+14	3	33	60.2%
3/27	OKC	L 131-113	34	15	9	0	1	0	1	7	1	14.3%	6	5	83.3%	13	6	46.2%	2	2	100.0%	0	9	0.0	-9	2	17	54.0%
3/25	PHI	L 157-137	29	18	8	2	1	0	3	10	4	40.0%	5	2	40.0%	15	6	40.0%	2	2	100.0%	3	5	0.7	-15	4	14	56.7%
3/23	HOU	W 132-124	34	23	4	1	0	0	3	9	5	55.6%	7	3	42.9%	16	8	50.0%	2	2	100.0%	1	3	0.3	+7	4	14	68.1%
3/19	CLE	L 115-110	32	13	5	0	3	3	2	9	2	22.2%	4	3	75.0%	13	5	38.5%	2	1	50.0%	1	4	0.0	-20	0	15	46.8%
3/18	TOR	L 139-109	30	19	7	1	1	2	2	8	3	37.5%	7	3	42.9%	15	6	40.0%	6	4	66.7%	2	5	0.5	-24	1	21	53.9%
3/16	MEM	W 132-107	31	29	7	1	3	0	1	13	5	38.5%	9	7	77.8%	22	12	54.5%	0	0	0.0%	2	5	1.0	+26	0	28	65.9%
3/13	LAC	L 119-108	34	18	11	2	0	0	2	10	2	20.0%	8	4	50.0%	18	6	33.3%	4	4	100.0%	3	8	1.0	-10	1	17	45.5%
3/12	LAL	L 142-130	35	22	6	1	2	2	2	11	4	36.4%	8	3	37.5%	19	7	36.8%	5	4	80.0%	1	5	0.5	-25	2	19	51.9%
3/10	GSW	W 130-124	45	41	6	2	2	2	1	15	5	33.3%	13	11	84.6%	28	16	57.1%	5	4	80.0%	1	5	2.0	+8	1	40	67.9%
3/8	SAC	L 126-110	30	20	8	4	3	0	3	6	2	33.3%	6	3	50.0%	12	5	41.7%	9	8	88.9%	1	7	1.3	-4	3	24	62.7%
3/3	OKC	L 116-108	20	11	5	3	0	0	1	5	2	40.0%	4	1	25.0%	9	3	33.3%	4	3	75.0%	1	4	3.0	+0	2	10	51.1%
3/1	MIL	W 120-97	31	20	7	3	3	0	3	9	4	44.4%	6	3	50.0%	15	7	46.7%	2	2	100.0%	0	7	1.0	+3	1	22	63.0%
2/26	POR	L 121-112	35	20	7	4	1	2	4	8	2	25.0%	8	4	50.0%	16	6	37.5%	9	6	66.7%	0	7	1.0	-15	4	16	50.1%
2/24	CHA	L 131-99	33	32	7	2	0	1	2	11	6	54.5%	8	7	87.5%	19	13	68.4%	0	0	0.0%	1	6	1.0	-7	2	33	84.2%
2/22	NYK	L 105-99	25	15	4	0	0	0	3	9	3	33.3%	3	1	33.3%	12	4	33.3%	5	4	80.0%	0	4	0.0	-6	3	6	52.8%
2/21	DET	L 126-110	30	15	6	3	6	2	4	7	2	28.6%	3	3	100.0%	10	5	50.0%	4	3	75.0%	0	6	0.8	-19	2	22	63.8%
2/19	TOR	L 110-101	31	4	6	1	0	0	4	7	0	0.0%	3	2	66.7%	10	2	20.0%	0	0	0.0%	2	4	0.3	-9	2	2	20.0%
2/11	BOS	L 124-105	28	15	8	4	2	1	2	7	3	42.9%	6	3	50.0%	13	6	46.2%	0	0	0.0%	0	8	2.0	-9	2	20	57.7%
2/9	BKN	L 123-115	26	18	4	1	3	0	3	7	3	42.9%	8	2	25.0%	15	5	33.3%	6	5	83.3%	0	4	0.3	-17	1	12	51.0%
2/7	DEN	L 136-120	30	21	8	3	0	1	3	8	4	50.0%	5	3	60.0%	13	7	53.8%	4	3	75.0%	0	8	1.0	-19	3	21	71.1%
2/5	TOR	L 123-107	32	18	6	3	1	1	3	6	2	33.3%	5	5	100.0%	11	7	63.6%	2	2	100.0%	1	5	1.0	-19	1	24	75.8%
2/3	MIL	L 131-115	35	22	2	1	5	0	1	10	5	50.0%	6	3	50.0%	16	8	50.0%	3	1	33.3%	0	2	1.0	-7	3	16	63.5%
2/1	MIA	L 134-91	21	2	3	2	3	0	3	5	0	0.0%	2	1	50.0%	7	1	14.3%	0	0	0.0%	1	2	0.7	-37	2	0	14.3%
1/31	MIA	W 125-118	33	21	8	4	1	0	8	7	3	42.9%	8	4	50.0%	15	7	46.7%	4	4	100.0%	0	8	0.5	+8	1	17	62.6%
1/29	MIA	L 116-113	33	16	9	4	1	1	1	5	2	40.0%	10	4	40.0%	15	6	40.0%	3	2	66.7%	3	6	4.0	+2	4	19	49.0%
1/28	IND	L 113-110	31	20	8	0	1	0	1	6	4	66.7%	5	3	60.0%	11	7	63.6%	2	2	100.0%	2	6	0.0	-8	1	25	84.2%
1/26	LAL	L 129-118	22	11	5	4	0	0	3	6	2	33.3%	2	2	100.0%	8	4	50.0%	2	1	50.0%	1	4	1.3	+9	2	11	61.9%
1/24	BOS	W 114-111	32	14	8	5	1	0	2	10	4	40.0%	3	1	33.3%	13	5	38.5%	0	0	0.0%	1	7	2.5	+15	2	15	53.8%
1/22	MIN	W 120-115	27	12	6	3	0	1	0	3	2	66.7%	5	1	20.0%	8	3	37.5%	4	4	100.0%	0	6	0.0	+1	2	17	61.5%
1/20	LAC	W 138-110	30	21	2	4	2	1	2	8	4	50.0%	6	4	66.7%	14	8	57.1%	2	1	50.0%	0	2	2.0	+27	2	20	70.6%
1/18	BKN	W 124-102	27	17	5	5	2	0	2	6	3	50.0%	7	3	42.9%	13	6	46.2%	2	2	100.0%	1	4	2.5	+15	1	20	61.2%
1/16	BKN	L 112-109	31	15	6	3	4	1	0	7	2	28.6%	8	2	25.0%	15	4	26.7%	6	5	83.3%	2	4	0.0	+7	2	17	42.5%
1/14	UTA	W 128-126	18	7	2	2	0	0	0	4	1	25.0%	3	2	66.7%	7	3	42.9%	0	0	0.0%	1	1	0.0	+0	2	6	50.0%
1/13	HOU	L 119-113	36	19	6	2	0	0	2	7	2	28.6%	7	5	71.4%	14	7	50.0%	4	3	75.0%	3	3	1.0	-13	3	16	60.3%
1/10	DAL	W 125-107	25	15	6	2	2	0	1	7	1	14.3%	9	6	66.7%	16	7	43.8%	0	0	0.0%	1	5	2.0	+19	3	10	46.9%
1/7	DET	L 108-93	32	20	3	1	4	1	2	7	4	57.1%	8	3	37.5%	15	7	46.7%	3	2	66.7%	0	3	0.5	-9	1	19	61.3%
1/5	BOS	L 115-101	30	26	3	2	1	0	2	4	3	75.0%	8	6	75.0%	12	9	75.0%	6	5	83.3%	0	3	1.0	-6	1	29	88.8%
1/3	CHA	L 112-99	34	17	8	3	0	0	3	8	2	25.0%	8	4	50.0%	16	6	37.5%	6	3	50.0%	3	5	1.0	-11	1	16	45.6%
1/2	ORL	W 121-114	30	21	9	7	2	1	2	8	2	25.0%	6	4	66.7%	14	6	42.9%	8	7	87.5%	1	8	3.5	+14	1	33	59.9%
12/31	NOP	W 134-118	27	19	6	2	0	1	0	9	2	22.2%	8	6	75.0%	17	8	47.1%	4	1	25.0%	1	5	0.0	+11	4	14	50.6%
12/29	MIN	L 136-101	23	13	5	2	1	0	2	8	3	37.5%	6	2	33.3%	14	5	35.7%	0	0	0.0%	2	3	1.0	-26	2	8	46.4%
12/27	MIL	L 112-103	22	8	3	2	0	1	3	3	1	33.3%	2	1	50.0%	5	2	40.0%	4	3	75.0%	1	2	0.7	-13	2	8	59.2%
12/26	PHI	W 109-102	19	10	8	0	3	0	3	6	2	33.3%	4	1	25.0%	10	3	30.0%	2	2	100.0%	2	6	0.0	-6	5	9	46.0%
12/23	ATL	W 126-123	18	15	2	0	2	0	0	3	2	66.7%	5	4	80.0%	8	6	75.0%	1	1	100.0%	0	2	0.0	-2	3	16	88.9%
12/21	ATL	W 152-150	28	28	3	0	2	1	0	8	7	87.5%	3	3	100.0%	11	10	90.9%	2	1	50.0%	0	3	0.0	+5	2	32	117.8%
12/19	CLE	W 136-125	33	24	5	1	2	2	0	8	2	25.0%	7	7	100.0%	15	9	60.0%	6	4	66.7%	1	4	0.0	+7	2	30	68.0%
12/17	CLE	W 127-111	22	9	1	1	1	0	1	2	0	0.0%	5	3	60.0%	7	3	42.9%	4	3	75.0%	0	1	1.0	+15	2	7	51.4%
12/14	NOP	L 114-104	23	9	6	3	0	1	0	3	1	33.3%	2	2	100.0%	5	3	60.0%	2	2	100.0%	1	5	0.0	-7	2	16	76.5%
12/12	CHA	W 129-126	23	10	0	1	2	0	0	2	0	0.0%	6	5	83.3%	8	5	62.5%	0	0	0.0%	0	0	0.0	+0	3	7	62.5%
12/7	GSW	L 123-91	24	16	3	1	1	3	2	5	2	40.0%	7	5	71.4%	12	7	58.3%	0	0	0.0%	2	1	0.5	-30	4	13	66.7%
12/5	IND	L 120-105	34	19	12	2	1	1	6	3	0	0.0%	5	5	100.0%	8	5	62.5%	9	9	100.0%	2	10	0.3	-8	2	30	79.4%
12/3	BKN	L 113-103	32	14	5	3	0	1	3	5	1	20.0%	9	5	55.6%	14	6	42.9%	2	1	50.0%	1	4	1.0	-7	2	9	47.0%
12/1	ORL	L 125-120	35	21	6	4	3	2	0	7	2	28.6%	9	5	55.6%	16	7	43.8%	6	5	83.3%	2	4	0.0	+5	3	26	56.3%
11/29	IND	L 103-101	34	8	11	2	3	1	3	5	2	40.0%	4	1	25.0%	9	3	33.3%	2	0	0.0%	4	7	0.7	-12	0	14	40.5%
11/28	CHA	L 123-116	29	8	2	3	0	1	2	5	0	0.0%	3	3	100.0%	8	3	37.5%	4	2	50.0%	0	2	1.5	+14	3	6	41.0%
11/24	NOP	L 143-130	21	10	4	0	2	0	2	5	2	40.0%	3	2	66.7%	8	4	50.0%	0	0	0.0%	0	4	0.0	-23	3	7	62.5%
11/22	WAS	W 121-120	29	13	6	1	3	1	1	6	1	16.7%	5	3	60.0%	11	4	36.4%	5	4	80.0%	0	6	1.0	+4	0	19	49.2%
11/21	MIA	L 143-107	18	6	5	1	2	1	2	3	0	0.0%	5	2	40.0%	8	2	25.0%	2	2	100.0%	1	4	0.5	-9	2	8	33.8%
11/19	POR	W 122-121	18	11	5	4	2	0	2	2	1	50.0%	4	3	75.0%	6	4	66.7%	2	2	100.0%	0	5	2.0	+4	3	17	79.9%
11/17	DEN	W 130-127	29	13	4	2	2	0	1	5	2	40.0%	9	3	33.3%	14	5	35.7%	1	1	100.0%	2	2	2.0	-14	2	7	45.0%
11/16	UTA	L 150-147	33	18	6	1	2	1	0	5	2	40.0%	8	5	62.5%	13	7	53.8%	3	2	66.7%	2	4	0.0	+3	6	19	62.8%
11/12	DET	L 124-113	33	21	14	2	2	0	4	5	2	40.0%	9	5	55.6%	14	7	50.0%	5	5	100.0%	2	12	0.5	+0	2	31	64.8%
11/10	SAS	L 121-117	24	15	5	0	1	1	1	3	2	66.7%	6	3	50.0%	9	5	55.6%	4	3	75.0%	1	4	0.0	-8	4	16	69.7%
11/8	CLE	L 128-122	17	4	4	0	0	0	3	3	0	0.0%	3	1	33.3%	6	1	16.7%	2	2	100.0%	0	4	0.0	-4	4	4	29.1%
11/7	MIL	L 126-110	35	20	8	3	1	2	3	6	2	33.3%	7	6	85.7%	13	8	61.5%	2	2	100.0%	2	6	1.0	-2	1	27	72.0%
11/4	PHI	W 113-111	30	10	5	1	2	1	2	4	2	50.0%	7	2	28.6%	11	4	36.4%	0	0	0.0%	0	5	0.5	+9	3	5	45.5%
11/2	NYK	L 128-116	31	14	8	0	0	1	1	6	4	66.7%	5	1	20.0%	11	5	45.5%	0	0	0.0%	1	7	0.0	+5	1	16	63.6%
10/31	NYK	W 135-125	29	13	0	1	1	1	1	5	2	40.0%	5	2	40.0%	10	4	40.0%	4	3	75.0%	0	0	1.0	-5	4	6	55.3%
10/29	SAC	W 126-113	33	27	5	2	1	2	3	6	4	66.7%	12	7	58.3%	18	11	61.1%	1	1	100.0%	2	3	0.7	+18	5	24	73.2%
10/27	ATL	W 128-123	32	16	5	3	0	0	1	7	2	28.6%	7	4	57.1%	14	6	42.9%	3	2	66.7%	1	4	3.0	+3	2	15	52.2%
10/25	ORL	W 110-98	12	3	3	0	0	1	2	2	0	0.0%	3	1	33.3%	5	1	20.0%	2	1	50.0%	1	2	0.0	+3	6	5	25.5%
10/22	DET	W 115-111	33	21	6	1	3	0	3	3	0	0.0%	9	7	77.8%	12	7	58.3%	7	7	100.0%	2	4	0.3	-10	3	22	69.6%
Regular Season Totals			29.2	16.3	5.8	2.0	1.5	0.7	2.1	6.4	2.3	35.6%	6.1	3.5	58.0%	12.4	5.8	46.5%	3.1	2.4	78.7%	1.0	4.8	1.0	-288	2.3	19.5	59.0%

Matas Buzelis: Breaking News

Buzelis (ankle) won't play Sunday in Dallas. With the Bulls playing for Ping Pong balls, Buzelis will hit the sidelines for their regular-season finale. His absence should open up minutes for Patrick Williams and Leonard Miller.

Buzelis won't return to Friday's game against the Magic due to a sprained right ankle. He'll finish with 14 points (6-17 FG, 0-9 3Pt, 2-3 FT), eight rebounds, three assists, three blocks and one steal in 27 minutes. Buzelis was cleared to return from a three-game absence due to an illness but picked up an ankle injury and exited to the locker room with 10:10 remaining in the fourth quarter. The second-year forward should be considered questionable for Sunday's regular-season finale in Dallas until the Bulls offer an update on his status.

Buzelis (illness) said he will play in Friday's game against the Magic, K.C. Johnson of Chicago Sports Network reports. Buzelis is set to shed his questionable tag and return from a three-game absence. The second-year forward has averaged 16.8 points, 8.0 rebounds, 2.2 assists and 1.4 blocks across 30.6 minutes per contest over his last five appearances.